A Hard Pill to Swallow: A Critical Look at Eli Lilly & Co.’s NAFTA Challenge of the Canadian Patent Regime, and Its Potential Side Effects
[James Damian Hakert] Abstract: ... NAFTA allowing pharmaceutical companies to successfully dispute national patent laws could have significant future consequences. This note outlines the circumstances surrounding Lilly’s dispute, analyzes the dispute’s viability, and explores various potential implications of the dispute going forward.